Aims/hypothesis The aim of this study was to understand the role of CXC chemokine receptor 3 (CXCR3), a T-helper 1(Th1) type chemokine receptor, in the pathogenesis of type 1 diabetes. 
mice, Tregs were more frequent in pancreatic lymph nodes and less frequent in pancreatic islets than in wild-type NOD mice. While Regulatory T cell Introduction Type 1 diabetes is an autoimmune disease that results from T cell-mediated destruction of insulin-producing pancreatic beta cells [1] . It is assumed that T-helper 1 (Th1) cells play an important role in the onset of type 1 diabetes [2] . In patients with type 1 diabetes, the serum level of CXC ligand (CXCL)10/IFN-γ-inducible protein of 10 kDa (IP-10), a Th1 type chemokine, is significantly higher than in healthy controls and patients with type 2 diabetes [3] . In NOD mice, CXCL10 is not constitutively expressed on pancreatic beta cells but is upregulated in response to a typical Th1-associated cytokine, IFN-γ, as insulitis progresses [4] . Administration of CXCL10 monoclonal antibodies to a cyclophosphamide-induced NOD diabetes mouse model resulted in delayed diabetes onset [5] . Moreover, induction of anti-CXCL10 antibodies using a gene transfer system in young NOD mice also resulted in disease suppression [4] . Therefore, we speculated that the receptor for CXCL10/IP-10, CXC chemokine receptor 3 (CXCR3), must be a key protein in the pathogenesis of type 1 diabetes.
CXCR3 is a G protein coupled receptor with seven transmembrane domains and its gene is encoded on the X chromosome in both mice and humans [6, 7] . Although this receptor is also expressed on Cd8 + T cells, B cells, macrophages, dendritic cells, natural killer (NK) cells and regulatory T cells (Tregs), it is expressed mainly on Th1 cells and can lead them to sites of tissue inflammation in response to CXCR3-binding chemokines, such as CXCL9/monokine induced by IFN-γ (Mig), CXCL10/IP-10 and CXCL11/ IFN-inducible T cell α chemoattractant (I-TAC) [6] [7] [8] [9] [10] [11] . Therefore, it is reasonable to assume that there is an amplification loop for Th1 immune responses between Th1 cells, which produce IFN-γ, and pancreatic beta cells, which produce CXCL10, in response to this cytokine, thereby attracting more Cxcr3-expressing Th1 cells to the affected site and amplifying the ongoing Th1 response. In fact, blockade of the CXCL10-CXCR3 interaction inhibited infiltration of lymphocytes into pancreatic islets and suppressed the onset of diabetes in a virus-induced diabetes model [12, 13] . Moreover, overexpression of CXCL10 in islets resulted in accelerated disease [14] . Thus, we speculated that knockout of CXCR3 would suppress the onset of diabetes. Surprisingly, however, instead we observed earlier diabetes onset in CXCR3-deficient NOD mice, and there was clear acceleration of diabetes development, compared with wild-type NOD mice, when an adoptive transfer system was used. In this paper we discuss the importance of CXCR3 + Tregs, so-called 'hybrid Tregs' [15] , in the regulation of type 1 diabetes, providing a possible explanation for the observations discussed above.
Methods

Animals
We purchased NOD and NOD-SCID mice from CLEA Japan (Tokyo, Japan). A female C57Bl/6 background CXCR3-deficient mouse was generated as previously described [16] . The mice were backcrossed to male NOD mice, and F1 female mice were again backcrossed to male NOD mice. From the F2 generation, heterozygous female mice were chosen and then backcrossed to male NOD mice. This manipulation was repeated until the sixth generation. At the fifth generation (F5), mice were screened for polymorphic microsatellite markers to determine whether they had the NOD gene background and we confirmed that they had NOD type on all markers shown in the electronic supplementary material (ESM) Fig. 1 [17] . Cxcr3 homozygous knockout female NOD mice were generated by crossing F6 knockout male and heterozygous female mice (speed congenic method). We housed all mice under specific pathogen-free conditions. All studies were approved by the Animal Care and Use Committee of Keio University.
Genotyping DNA was extracted from a small portion of the tail of experimental mice. A QIAGEN DNeasy kit (Qiagen, Courtaboeuf, France) was used for DNA isolation, followed by PCR using TaKaRa Ex Taq (TAKARA BIO, Shiga, Japan). Genotyping was performed using primers recognising Cxcr3 genomic DNA sequences or inserted genomic DNA sequences named Neu. The primers shown in ESM Table 1 were used. The wild-type allele yielded a 589 bp DNA fragment and the knockout allele a 320 bp fragment, which were analysed using agarose gels and detected by ethidium bromide (EtBr) staining. Flow cytometric analysis confirmed that CXCR3 on splenocytes was decreased in heterozygous mice and was undetectable in knockout mice (ESM Fig. 2 ).
Definition of diabetes All animals were assessed for glycosuria at least once a week in the evening, and plasma glucose was measured when glycosuria was observed. Being positive for glycosuria and having a plasma glucose level higher than 13.9 mmol/l confirmed diabetes.
Histological examination
The pancreas was removed from mice, fixed in 10% formaldehyde and embedded in paraffin. Thin sections at four levels, 200 μm apart, were cut for hematoxylin-eosin (H&E) staining to evaluate the degree of cell infiltration in the islets by light microscopy. The pancreatic islets were scored using the following rankings: grade 0, normal; grade 1, peri-insulitis (mononuclear cells surrounding islets and ducts, but no infiltration of the islet architecture); grade 2, moderate insulitis (mononuclear cells infiltrating <50% of the islet architecture); and grade 3, severe insulitis (mononuclear cells infiltrating >50% of the islet architecture).
Quantitative RT-PCR Total RNA was extracted from the pancreas, pancreatic lymph nodes (pLN) and spleen using an RNeasy Mini kit (Qiagen). During the procedure, DNase treatment was performed according to the manufacturer's protocol. The extracted RNA was reverse transcribed using Not I-d(T)18 primer and a First-Strand cDNA synthesis kit (GE Healthcare, Little Chalfont, UK), according to the manufacturer's instructions. Quantitative RT-PCR was conducted for Il4, Il10, Tgf-β (also known as Tgfb1), Foxp3, Ifn-γ (also known as Ifng), Il2, Gzmb, Ccr5 and Gapdh (internal control) in an ABI Prism 7700 sequence detector (Applied Biosystems, Foster City, CA, USA). The primers were purchased from Applied Biosystems. All reactions were performed using TaqMan Universal MasterMix (Applied Biosystems). The expression of each gene was normalised to that of Gapdh.
Immunohistochemical study The pancreases removed from NOD mice were inflated with optimal cutting temperature (OCT) compound and snap-frozen in liquid nitrogen. Following this, 4% paraformaldehyde (PFA)-fixed 6 μm thick fresh frozen tissue sections were blocked with 5% goat serum diluted in PBS. The sections were incubated with polyclonal guinea pig anti-swine insulin antibody (DakoCytomation, Kyoto, Japan), fluorescein isothiocyanate (FITC)-labelled rat anti-mouse CD4 monoclonal antibody (mAb) (H129.19; BD Pharmingen, San Diego, CA, USA), rat anti-mouse FOXP3 antibody (MF333F; Alexis Biochemicals, Plymouth Meeting, PA, USA), rabbit antimouse FOXP3 antibody (PA1-46126; Thermo Fisher Scientific, Rockford, IL, USA), and phycoerythrin (PE)-labelled rat anti-mouse CXCR3 mAb (R&D Systems, Minneapolis, MN, USA), followed by Alexa Fluor-594-labelled goat antiguinea pig IgG, Alexa Fluor-488-labelled goat anti-rat IgG and Alexa Fluor-568-labelled goat anti-rabbit IgG (Molecular Probes, Eugene, OR, USA). The sections were then examined by fluorescence microscopy. We ensured staining specificity by using control slides in which incubation with the primary antibody was skipped. Thin sections at three levels, 200 μm apart, were cut to evaluate the islets.
Flow cytometry Cell surfaces were stained with the following directly conjugated antibodies specific for mouse proteins: FITC or PE-labelled anti-mouse CD4 mAb (H129.19; BD Pharmingen) or PE-labelled anti-mouse CXCR3 mAb (R&D Systems). Mouse FOXP3 staining was performed with a FITC anti-mouse FOXP3 staining set (eBioscience, San Diego, CA, USA).
To perform flow cytometric analyses of pancreases, approximately 2.5 ml of cold HBSS (Sigma-Aldrich, St Louis, MO, USA) containing collagenase XI (1 mg/ml; SigmaAldrich) was injected into the common bile duct. The distended pancreas was removed and incubated at 37°C for 17 min with shaking. Cold HBSS was added to stop the digestion. The pancreas was then dissected using a cell strainer and stained with the same monoclonal antibodies as the spleen cell preparations. The stained cells were analysed with an Epics XL-MCL (Beckman Coulter, Brea, CA, USA). Cell transfer For the adoptive transfer experiments, the spleens of non-diabetic and diabetic Cxcr3 −/− and wildtype 14-18-week-old NOD mice were removed. After lysis of erythrocytes, the splenocytes were washed with PBS. The splenocytes were then resuspended at an appropriate concentration for transfer (8.0×10 6 cells/ml), and 250 μl of the cell suspension (including 2.0×10 6 cells) was injected intraperitoneally into each NOD-SCID recipient.
Suppression assay
For the migration study, the spleens of 27-week-old diabetic wild-type NOD mice were removed. After lysis of erythrocytes, the splenocytes were washed with PBS and incubated with FITC-labelled anti-mouse CD4 mAb (H129.19; BD Pharmingen) and PE-labelled anti-mouse CXCR3 mAb (R&D Systems). CXCR3
− CD4 + and CXCR3 + CD4 + cells were isolated by sorting using an Altra HyperSort System (Beckman Coulter). The splenocytes were then resuspended at an appropriate concentration for transfer (8.0×10
5 cells/ml), and 250 μl of the cell suspension (including 2.0×10 5 cells) was injected intraperitoneally into each NOD-SCID recipient. Eleven weeks later, the recipients were killed and the pancreas was examined histologically.
For ESM Fig. 3 ). Furthermore, when we transferred Cxcr3 −/− NOD splenocytes into NOD-SCID mice, the incidence of diabetes was higher (Cxcr3 −/− nondiabetic 100% vs wild-type non-diabetic 10% at 9 weeks after transfer, p<0.01, Cxcr3 −/− diabetic 100% vs wild-type diabetic 42.1% at 9 weeks after transfer, p00.01, Fig. 2 ) and the onset was earlier than in NOD-SCID recipients of wildtype NOD splenocytes, confirming that Cxcr3 −/− NOD spleen cells were clearly more immunologically active than wild-type NOD spleen cells.
Mirror image expressions of Treg element in pancreatic lymph nodes and pancreas To gain insight into the earlier onset of diabetes in Cxcr3 −/− NOD mice, we examined cytokine expression levels in the pancreatic lymph nodes and pancreas from prediabetic 12-week-old Cxcr3 −/− NOD mice, which are considered to represent the stage immediately before the onset of diabetes, and compared the findings with those in age-matched wild-type NOD mice. As shown in Fig. 3 , expression levels of Tgf-β, Foxp3, Il10 and Il4 were higher in pancreatic lymph nodes from Cxcr3 −/− NOD mice, whereas expression levels were lower in the pancreas, with these levels being a 'mirror image' of each other. 
CD4
+ cells migrated into the recipient islets (Fig. 6a) . These infiltrating cells were confirmed to be CD4 + cells (Fig. 6c) . Furthermore, a portion of these cells contained FOXP3 (Fig. 6d) 
+ cells from the same donor into NOD-SCID recipients, there was no cell infiltration in the recipient islets by 11 weeks post-transfer (Fig. 6b) 
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Relative Treg-transferred mice developed diabetes by 11 days post cyclophosphamide injection, whereas none of the wild-type Treg-transferred mice developed diabetes at the same time point (p00.02). The incidence of diabetes at 18 days post cyclophosphamide treatment in NOD mice without transfer was 42% (8/19) in this system. These results indicate that the presence of CXCR3 in Tregs effectively suppresses diabetes in vivo.
Discussion
Numerous reports [2, [19] [20] [21] [22] have clarified that Th1 cells are intimately involved in the onset of type 1 diabetes. In this study, we generated NOD mice lacking CXCR3, which has been considered to make a major contribution to the cytotoxic functions of Th1 cells, and we anticipated that diabetes onset in these mice would be delayed or suppressed.
The results, however, were entirely the opposite of our expectations.
Other researchers have investigated the role of CXCR3 by using Cxcr3 gene deficient mice. Gao et al. [23] reported that, in a bleomycin-induced lung injury model, Cxcr3 knockout mice were protected from lung injury as evidenced by lower accumulation of inflammatory cells in the airways and lung interstitium than in their wild-type littermates. As with our initial expectation, they also assumed that CXCR3 signalling would promote inflammatory cell recruitment and initiate an inflammatory cytokine cascade following endotracheal bleomycin administration. In this study we examined the mRNA expression level of a Th1-type cytokine, Ifn-γ, in the pancreases from Cxcr3 −/− mice, and found the level to be similar to that in wild-type mice (data not shown). This result suggested that CXCR3-deficient Th1 cells migrated in the same manner as wildtype Th1 cells, using other chemokine receptors independent of CXCR3, such as CCR5, which we confirmed to be present in pancreases from Cxcr3 −/− NOD mice (data not shown).
On the other hand, Müller et al. [11] reported that, in the central nervous system (CNS) in experimental autoimmune encephalomyelitis (EAE), the times to onset and peak disease severity were similar in Cxcr3 knockout and wild-type animals. However, Cxcr3 knockout mice had more severe chronic disease, with increased demyelination and axonal damage. Although the numbers of CD4 + and CD8 + T cells infiltrating the CNS were similar in Cxcr3 knockout and wild-type mice, FOXP3 + regulatory T cells were significantly reduced in number and were more dispersed in Cxcr3 knockout mice. The authors concluded that, in EAE, CXCR3 signalling kept T cells within the perivascular space in the CNS and augmented regulatory T cell recruitment and interaction between regulatory T cells and effector T cells, thereby limiting autoimmune-mediated tissue damage. In our experimental system, mRNA expression patterns clarified the marked differences in location of regulatory T cells between Cxcr3 −/− and wild-type NOD mice. In Cxcr3 −/− mice, regulatory T cells accumulated in pancreatic lymph nodes, with fewer being detected in pancreatic islets. These findings suggest that CXCR3 is a chemokine receptor for regulatory T cell migration into pancreatic islets, and that the earlier onset of diabetes in Cxcr3 −/− mice may be due to lack of regulatory T cells in pancreatic islets. + FOXP3 + cells was significantly higher in both pancreatic lymph nodes and among splenocytes from 29-week-old (malignant phase) NOD mice than in those from 10-week-old (benign phase) NOD mice (ESM Fig. 7 ). Taken together, these results suggest that CXCR3 + FOXP3 + CD4 + cells are generated mainly in the malignant phase, in response to IFN-γ. As we reported previously, the IFN-γ response increased immediately prior to (or after) the onset of diabetes [2] . In general, the IFN-γ response in NOD mice during the non-diabetic phase is lower than that in the normal strain, whereas the IFN-γ response recovers to a 'normal' level at approximately the time of diabetes onset [2] . Our previous observations support our current hypothesis that CXCR3
+ cell generation coincides with or occurs shortly after the onset of diabetes.
As mentioned in the Introduction, blockade of the CXCL10-CXCR3 interaction inhibited infiltration of lymphocytes into pancreatic islets and suppressed the onset of diabetes [14, 25] . These data are from a virus-induced diabetes model in which CXCL10 is acutely produced after infection, and therefore the migration of possibly both effector as well as regulatory T cells has been blocked. Both effector and regulatory T cells might be attracted in excess, leading to disease acceleration, despite the possible presence of a higher absolute number of 'hybrid Tregs'. Hybrid Tregs producing CXCR3 might be more important in a spontaneous model with slow disease progression.
One might argue that the function of Tregs might be different between Cxcr3 −/− and wild-type NOD mice. However, Tgf-β, Il10, Il4, Ifn-γ, Il-2 and Gzmb expression levels of sorted FOXP3 + cells (data not shown), as well as the suppressive function of CD4 + CD25
+ cells in vitro, were essentially the same in the two strains. Therefore, we consider that the function of Tregs must be the same in the two strains.
Considering the clinical situation, after sorting this CXCR3 + Treg population at the onset of diabetes, and the expansion of this population, these cells might be used to regulate the active disease state through transfer back into the donor. We examined whether Tregs from wild-type mice, which were considered to include CXCR3 + Funding This study was partly funded by a Grant-in-Aid for Scientific Research.
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